Other Issues

Select an Issue

Browse Other Issues Content

scientist with long dark hair in a lab facing away
Volatile Organic Compounds

While VOCs can have environmental impacts in aggregate, existing alternatives don’t always provide the consistent therapeutic results needed for OTC products relied upon by millions for. As such, any legislation aimed at further restricting pharmaceutical VOCs must carefully weigh potential unintended consequences on public health.

hands in sterile gloves holding manufactured white tablets

Industry Self-Regulation for Dietary Supplements

SIDI Protocol Version 3.0

The Standardized Information on Dietary Ingredients (SIDITM) Protocol is intended to serve as a standardized format that can be used consistently across the dietary supplement industry.

red capsules being sorted in a circular hopper

FAQs

FAQs About Manufacturing Quality

Learn about how CHPA member companies ensure that OTC medicine quality is standardized across the U.S.

Profile view of Hispanic/Latinx young boy drinking medicine against white background
Background Summary: Pediatric Acetaminophen Dosing

FDA Announcement of a proposed safety-based Administrative Order (AO) to address dosage strengths of oral, single ingredient, pediatric acetaminophen products. This AO proposal includes the addition of weight and age-based dosing for children under age 12.

Test tubes lying on their sides
Emergency Scheduling of Ingredients

CHPA has concerns with granting unilateral authority to temporarily schedule substance restrictions, without legislative oversight or consent

dandelion, capsules, and brown bottle

Informed Consumer Decision Making

Voluntary Labeling Program for Dietary Supplements Proposed St. John's Wort Information Statement

Members of the Consumer Healthcare Products Association who market dietary supplements containing St. John's wort initiated a voluntary labeling program on April 2, 2000.

parents with sick children
Understanding the CARES Act, the COVID-19 Relief Package

Find comprehensive resources for understanding the CARES Act and its impact.

Test Tubes
Animal Testing

CHPA generally supports prohibitions on animal testing while allowing exemptions in select research areas deemed critical to substantiating human health and safety based on federal or state regulator evaluations.

scientist with long dark hair in a lab facing away
Guideline for the Stability Testing of Nonprescription (OTC) Drug Products Not Regulated by an NDA/ANDA

The objective of this guideline is to define the minimum stability data package to support the commercial distribution of OTC monograph drug products in the United States per climatic zone.

Customer in Store Looking at Label

Transparency

Dietary Supplement Label Database (DSLD)

To address the growing need for more information on dietary supplements available in the market, the Office of Dietary Supplements at the National Institutes of Health has developed the Dietary Supplement Label Database. This valuable resource compiles comprehensive information obtained from the labels of dietary supplement products sold in the United States.

Filter Results